Breast cancer genomics and immuno-oncological markers to guide immune therapies.

Hammerl, D; Smid, M; Timmermans, A M; Sleijfer, S; Martens, J W M; Debets, R

Hammerl, D; Smid, M; Timmermans, A M; Sleijfer, S; Martens, J W M; Debets, R.

Afiliación

Hammerl D; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Smid M; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Timmermans AM; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Sleijfer S; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Martens JWM; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands.
Debets R; Department of Medical Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands. Electronic address: j.debets@erasmusmc.nl.

Semin Cancer Biol ; 52(Pt 2): 178-188, 2018 10.

Article en En | MEDLINE | ID: mdl-29104025

Asunto(s)

Biomarcadores de Tumor/inmunología; Neoplasias de la Mama/genética; Neoplasias de la Mama/terapia; Neoplasias de la Mama/inmunología; Neoplasias de la Mama/patología; Femenino; Genómica/métodos; Humanos; Inmunoterapia/métodos; Oncología Médica/métodos; Pronóstico

Palabras clave

Antigens; Breast cancer; Immune evasive mechanisms; Immune-oncological markers; Immunotherapy; TILs

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Semin Cancer Biol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google